Sign in
Not yet recruitingNo phase

Evaluating Medication Adherence of Patients With Gastroesophageal Reflux Disease With Support of Smartphone Application GERDCare

Key facts

Who runs it
Institute of Gastroenterology and Hepatology, Vietnam
Where
Vietnam1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
380 people, planned
Started
15 Aug 2025
Planned end
31 Oct 2025
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Mobile application GERDCare
Record updated
17 August 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (7)Hide the full registry criteria

Who can take part

  • ≥18 years old
  • Presents with typical GERD symptoms (regurgitation, heartburn)
  • Owns a smartphone and capable of using smartphone applications

Who cannot take part

  • Acute GI conditions (upper GI bleeding, acute peptic ulcer…)
  • GI malignancy (esophageal cancer, gastric cancer…)
  • Severe chronic comorbidities (heart failure, liver failure, chronic kidney disease…)
  • Pregnancy, alcohol abuse, mental health conditions impacting medication adherence or app usage

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Gerd

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Adherence to GERD treatment, including medication, diet, and lifestyle, is essential for symptom control and complication prevention, yet adherence rates remain low due to various demographic and clinical factors. Digital therapeutics, particularly mobile health applications, have shown promising potential in supporting chronic disease management and improving patient outcomes.

Read full original descriptionShow less

The GERDCare mobile application was developed with direct input from gastrointestinal experts. It is designed to enhance treatment adherence and patient engagement by offering features such as educational resources, symptom tracking, medication reminders, and direct communication between patients and physicians.

We are conducting a single-center, open-label, randomized controlled trial to evaluate the effectiveness of using GERDCare in improving patient adherence. Patients are followed up after four weeks of GERD treatment.

The 2 groups in the trial

  • Using GERDCareTreatment being tested

    Using the mobile application GERDCare (detailed instructions provided at the time of the recruitment)

    Treatment: Mobile application GERDCare

  • Not using GERDCareNo study treatment, for comparison

    Not using the mobile application GERDCare

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluating Medication Adherence of Patients With Gastroesophageal Reflux Disease With Support of the Smartphone Application GERDCare
Criteria questions
Built from NCT07127276, who can take part
Record updated
17 August 2025